In light of surprising assertion of 86% ownership not only of Live Tissue Connect, Inc. but also of LTC patents, would existing shareholders be better off if CSMG simply auctioned off LTC patents to highest bidder? That move sidesteps what arguably appears as massive dilution coming down the pike not to mention the hole left by Aegis Capital.
The open question: is 86% of the monetized value of IP worth more to shareholders than a potentially Lilliputian percentage of a start-up firm with attached risk?
ctgi
These are my opinions and sentiments. Buying stocks poses demonstrable risks; you could lose all or part of your principal investment. Use iBoxes for DD start.
Buying gold won't save your soul, but it might save your skin someday.